Research programme: histone deacetylase inhibitors - Argenta Discovery
Alternative Names: ADS 102550; HDAC inhibitors research programme - Argenta DiscoveryLatest Information Update: 26 Jul 2010
Price :
$50 *
At a glance
- Originator Argenta Discovery
- Class
- Mechanism of Action Histone deacetylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 25 Jun 2004 Compounds from this programme are available for licensing in (http://www.argentadiscovery.com)
- 24 Mar 2004 Preclinical trials in Cancer in United Kingdom (unspecified route)